Group 1 - The core viewpoint of the news highlights the recent performance of United Medical (00722.HK) in the Hong Kong stock market, noting a 6.74% increase in share price despite a broader market decline [1] - Over the past month, United Medical has seen a cumulative increase of 5.95%, and a year-to-date increase of 12.1%, which is lower than the Hang Seng Index's increase of 18.2% [2] - Financial data shows that as of December 31, 2024, United Medical achieved total revenue of 344 million yuan, a year-on-year decrease of 1.22%, while net profit attributable to shareholders was 16.62 million yuan, a year-on-year increase of 14.55% [2] Group 2 - Currently, there are no institutional investment ratings for United Medical [3] - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -21.64 times, with a median of 0.36 times; United Medical's P/E ratio stands at 8.41 times, ranking 10th in the industry [3] - United Medical Group Limited, established in 1990, is a leading healthcare platform in Hong Kong and Macau, providing diverse medical services and collaborating with enterprises and insurance companies to manage healthcare benefit plans [4]
联合医务（00722.HK）6月19日收盘上涨6.74%，成交17.09万港元